Sousa E Silva Rita, Sousa André Dias, Vieira Jorge, Vieira Cristina P
Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal.
Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, Portugal.
Front Mol Neurosci. 2023 Mar 15;16:1140719. doi: 10.3389/fnmol.2023.1140719. eCollection 2023.
Spinocerebellar ataxia type 3, also known as Machado-Joseph disease (SCA3/ MJD), is the most frequent polyglutamine (polyQ) neurodegenerative disorder. It is caused by a pathogenic expansion of the polyQ tract, located at the C-terminal region of the protein encoded by the gene. This gene codes for a deubiquitinating enzyme (DUB) that belongs to a gene family, that in humans is composed by three more genes (, , and ), that define two gene lineages (the and the Josephins). These proteins have in common the N-terminal catalytic domain (Josephin domain, JD), that in Josephins is the only domain present. In knock-out mouse and nematode models, the SCA3 neurodegeneration phenotype is not, however, reproduced, suggesting that in the genome of these species there are other genes that are able to compensate for the lack of . Moreover, in mutant , where the only JD protein is coded by a Josephin-like gene, expression of the expanded human gene reproduces multiple aspects of the SCA3 phenotype, in contrast with the results of the expression of the wild type human form. In order to explain these findings, phylogenetic, as well as, protein-protein docking inferences are here performed. Here we show multiple losses of JD containing genes across the animal kingdom, suggesting partial functional redundancy of these genes. Accordingly, we predict that the JD is essential for binding with ataxin-3 and proteins of the Josephin lineages, and that mutants are a good model of SCA3 despite the absence of a gene from the lineage. The molecular recognition regions of the ataxin-3 binding and those predicted for the Josephins are, however, different. We also report different binding regions between the two ataxin-3 forms (wild-type (wt) and expanded (exp)). The interactors that show an increase in the interaction strength with exp ataxin-3, are enriched in extrinsic components of mitochondrial outer membrane and endoplasmatic reticulum membrane. On the other hand, the group of interactors that show a decrease in the interaction strength with exp ataxin-3 is significantly enriched in extrinsic component of cytoplasm.
3型脊髓小脑共济失调,也称为马查多-约瑟夫病(SCA3/MJD),是最常见的多聚谷氨酰胺(polyQ)神经退行性疾病。它由位于该基因编码蛋白C末端区域的多聚谷氨酰胺序列的致病性扩增引起。该基因编码一种去泛素化酶(DUB),属于一个基因家族,在人类中该家族还由另外三个基因(、和)组成,这三个基因定义了两个基因谱系(和约瑟夫蛋白家族)。这些蛋白质的共同之处在于其N末端催化结构域(约瑟夫蛋白结构域,JD),在约瑟夫蛋白家族中这是唯一存在的结构域。然而,在敲除小鼠和线虫模型中,并未重现SCA3神经退行性变表型,这表明在这些物种的基因组中存在其他能够补偿缺失的基因。此外,在突变体中,唯一的JD蛋白由一个类约瑟夫蛋白基因编码,与野生型人类形式的表达结果相反,扩增的人类基因的表达重现了SCA3表型的多个方面。为了解释这些发现,本文进行了系统发育分析以及蛋白质-蛋白质对接推断。我们在此表明,在动物界中含有JD的基因多次丢失,提示这些基因存在部分功能冗余。因此,我们预测JD对于与ataxin-3和约瑟夫蛋白家族的蛋白质结合至关重要,并且尽管缺失了家族中的一个基因,突变体仍是SCA3的良好模型。然而,ataxin-3结合的分子识别区域与为约瑟夫蛋白预测的值不同。我们还报告了两种ataxin-3形式(野生型(wt)和扩增型(exp))之间不同的结合区域。与exp ataxin-3相互作用强度增加的相互作用蛋白,在线粒体外膜和内质网膜的外在成分中富集。另一方面,与exp ataxin-3相互作用强度降低的相互作用蛋白组在细胞质的外在成分中显著富集。